38256

Modulation of the expression of different S6Ks isoforms in prostate cancer cell lines leads to alterations in proliferation, migration and chemotherapy resistance

Favoritar este trabalho
Many works have demonstrated the participation of the mTOR pathway in cancer, but there is currently a demand to better characterize the S6Ks isoforms in this disease. The present work aimed to study the effects of S6Ks overexpression in cellular assays using prostate cancer cells.Our results indicate that p85-S6K1 isoform enhanced proliferation and colony formation of DU145 and PC3 cells. Besides, overexpression of S6K isoforms increased the docetaxel resistance of PC3 cells.